IP Library Granted Patent US 12,018,010
Granted Patent B2
US 12,018,010 · App. 17/428,415 · Granted Jun 25, 2024

Method for preparing efinaconazole using ionic liquid as medium

Inventors: Eun Ju Park (Hwaseong-si, KR); Hyun Ji (Siheung-si, KR); Ji Eun Lee (Busan, KR); Jin Oh Park (Seoul, KR)
Assignee: Daebong Ls Co., Ltd.
C07D401/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,018,010
App. No.
17/428,415
Granted
Jun 25, 2024
Kind
B2
Abstract

The present invention relates to a novel method for preparing efinaconazole using an ionic liquid as a medium. The method includes subjecting 1-[[(2R,3S)-2-(2,4-difluorophenyl)-3-methyloxiranyl]methyl]-1H-1,2,4-triazole to a coupling reaction with 4-methylenepiperidine or an organic chemically acceptable salt thereof in the presence of a base and an ionic liquid compound. The base makes the 4-methylenepiperidine or organic chemically acceptable salt thereof anionic. The use of the ionic liquid in the method of the present invention prevents the formation of related substances, shortens the reaction time, and enables easy preparation of the final compound efinaconazole in high purity and yield on a large scale, compared to the use of organic solvents in conventional methods.

Claims (4)

1. A method for preparing efinaconazole, the method comprising subjecting 1-[[(2R, 3 S)-2-(2,4-difluorophenyl)-3-methyl oxiranyl]methyl]-1H-1,2,4-triazole to a coupling reaction with 4-methylenepiperidine or an organic chemically acceptable salt thereof in the presence of a base and an ionic liquid compound,

wherein the ionic liquid compound is an imidazolium alkyl sulfate.

2. The method according to claim 1 , wherein the ionic liquid compound includes 1-ethyl-3-methylimidazolium ethyl sulfate.

3. The method according to claim 1 , wherein the base includes potassium t-butoxide, sodium t-butoxide, NaH, NaOH, KOH, or mixtures thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 4, 2021
From: PARK, EUN JU; JI, HYUN; LEE, JI EUN; PARK, JIN OH
To: DAEBONG LS CO., LTD.
Reel/Frame 057262/0075 →
Priority Claims (1)
KR 10-2019-0118645 · Sep 26, 2019 · national
Continuity (1)
Related Publication 20220127245A1 · Apr 28, 2022